Comparison Between Tailored Surgery Versus Total Mesorectal Excision in ycT2-3N0M0

NCT05164315 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-12-05

No results posted yet for this study

Summary

The purpose of this study is to show that tailored treatment based on local excision can expand the target of non-radical treatment in ycT2-3N0M0 patients after neoadjuvant chemoradiotherapy for low rectal cancer and that the oncologic safety is not inferior to that of total mesorectal excision.

Conditions

  • Rectal Cancer, Adenocarcinoma

Interventions

PROCEDURE

Tailored surgery

Procedure: Tailored surgery based on intraoperative local excision/biopsy

PROCEDURE

Total mesorectal excision (TME)

Procedure: Total mesorectal excision for all allocated patients

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2024-08-26
Completion
2024-08-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05164315 on ClinicalTrials.gov